Aberrant HER3 expression is involved in carcinogenesis and the progression of diverse human cancers24, and its activation has been observed in the active PI3K/AKT signaling feedback loop in HER2-driven breast cancer cells treated with EGFR or HER2 inhibitors25. This evidence concerns the gene ERBB3 and breast cancer.